Only in Titles

           Search results for: Comet Assay Tank for 20 Slides   

paperclip

#17333193   // Save this To Up

Validation of the comet-X assay as a pharmacodynamic assay for measuring DNA cross-linking produced by the novel anticancer agent RH1 during a phase I clinical trial.

RH1 is a novel anticancer agent with potent DNA-cross linking activity. RH1 has the potential to be activated within tumors over expressing NQO1, giving maximal antitumour activity with reduced toxicity in normal tissues. RH1 has recently completed a Cancer Research UK sponsored phase I clinical trial at two different centers in the United Kingdom. The comet-X assay was a secondary endpoint in this trial and assay validation was necessary. We describe here this validation process. Whilst it is impossible to cover all variations/conditions of a pharmacodynamic assay, we have strived to evaluate and demonstrate that this assay conforms to the three R's of validation, that is robustness, reliability and reproducibility.

2921 related Products with: Validation of the comet-X assay as a pharmacodynamic assay for measuring DNA cross-linking produced by the novel anticancer agent RH1 during a phase I clinical trial.

Apoptotic DNA Ladder Isol Mitochondrial DNA Isolati Mitochondrial DNA Isolati Genomic DNA Isolation Kit ApoBrdU IHC DNA Fragmenta ApoBrdU IHC DNA Fragmenta MarkerGeneTM Live Dead As OxiSelectâ„¢ Cellular UV- Mouse anti-chick type I c Mouse anti-chick type I c Mouse anti-bovine type I Mouse anti-bovine type I

Related Pathways

  •  
  • No related Items